Regenicin Stock Analysis
| RGIN Stock | USD 0.0001 0.00 0.00% |
Regenicin is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Regenicin pink sheet analysis is to determine its intrinsic value, which is an estimate of what Regenicin is worth, separate from its market price. There are two main types of Regenicin's stock analysis: fundamental analysis and technical analysis.
The Regenicin pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Regenicin |
Regenicin Pink Sheet Analysis Notes
About 18.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.0. Regenicin had not issued any dividends in recent years. The entity had 34:1 split on the 2nd of August 2010. Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey. Regenicin operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.The quote for Regenicin is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Regenicin contact Randall McCoy at 973 557 8914 or learn more at https://www.regenicin.com.Regenicin Investment Alerts
| Regenicin generated a negative expected return over the last 90 days | |
| Regenicin has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (639.26 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Regenicin currently holds about 2.24 K in cash with (27.29 K) of positive cash flow from operations. | |
| Roughly 18.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from express.co.uk: The renowned British brand that risks alienating its loyal customers |
Regenicin Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 214.88 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Regenicin's market, we take the total number of its shares issued and multiply it by Regenicin's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Regenicin, as well as the relationship between them.Regenicin Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Regenicin middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Regenicin. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Regenicin Outstanding Bonds
Regenicin issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Regenicin uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Regenicin bonds can be classified according to their maturity, which is the date when Regenicin has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| REGENERON PHARMACEUTICALS INC Corp BondUS75886FAF45 | View | |
| REGENERON PHARMACEUTICALS INC Corp BondUS75886FAE79 | View | |
| US75884RBA05 Corp BondUS75884RBA05 | View | |
| REGENCY CTRS L Corp BondUS75884RAV50 | View | |
| US75884RAW34 Corp BondUS75884RAW34 | View |
About Regenicin Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Regenicin prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Regenicin shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Regenicin. By using and applying Regenicin Pink Sheet analysis, traders can create a robust methodology for identifying Regenicin entry and exit points for their positions.
Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey. Regenicin operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Regenicin to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Other Information on Investing in Regenicin Pink Sheet
Regenicin financial ratios help investors to determine whether Regenicin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Regenicin with respect to the benefits of owning Regenicin security.